Standardized Physician-modified Fenestrated Endograft Registry

Launched by UNIVERSITY HOSPITAL PADOVA · Apr 7, 2024

Keywords

ClinConnect Summary

The Standardized Physician-modified Fenestrated Endograft Registry is a clinical trial that looks at a specific treatment for complex aortic aneurysms, which are balloon-like bulges in the aorta that can be dangerous if they grow too large. This study involves multiple centers and examines patients who have received a modified type of endograft, a device used to repair these aneurysms. The goal is to gather information about how well this treatment works in different patients.

To participate in this trial, patients typically need to be between the ages of 65 and 74 and have specific types of complex aortic aneurysms that meet certain criteria, such as having a healthy part of the aorta above the aneurysm. Patients must also be stable and not in immediate danger due to bleeding. If someone is eligible, they can expect to be part of a study that collects data over time to help improve future treatments for aortic diseases. It's important to know that this trial is currently recruiting participants, so there are opportunities to join if the criteria are met.

Gender

ALL

Eligibility criteria

• • INCLUSION CRITERIA
• • Complex AAA (including short-neck AAA, JRAA, PRAA, extent IV TAAA)
• • Haemodynamic stability
• • Anatomical feasibility is based on the presence of a proximal aortic neck above the mid celiac trunk of ≥25 mm in length and between 18 mm and 35 mm in diameter; the neck needs to be "healthy" with no parietal calcifications or thrombus with a cylindrical shape. The visceral aorta is required to be no larger than 40 mm in maximum diameter.
• • EXCLUSION CRITERIA
• • Extent I-III TAAA
• • Hemorrhagic shock